PL2097064T3 - Terapia anaplerotyczna choroby Huntingtona i innych chorób poliglutaminowych - Google Patents
Terapia anaplerotyczna choroby Huntingtona i innych chorób poliglutaminowychInfo
- Publication number
- PL2097064T3 PL2097064T3 PL07847692T PL07847692T PL2097064T3 PL 2097064 T3 PL2097064 T3 PL 2097064T3 PL 07847692 T PL07847692 T PL 07847692T PL 07847692 T PL07847692 T PL 07847692T PL 2097064 T3 PL2097064 T3 PL 2097064T3
- Authority
- PL
- Poland
- Prior art keywords
- huntington disease
- polyglutamine diseases
- anaplerotic therapy
- anaplerotic
- therapy
- Prior art date
Links
- 208000023105 Huntington disease Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229920000155 polyglutamine Polymers 0.000 title 1
- 108010040003 polyglutamine Proteins 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
- A23L29/04—Fatty acids or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06291873A EP1929995A1 (en) | 2006-12-04 | 2006-12-04 | Anaplerotic therapy of Huntington disease and other polyglutamine diseases |
| EP07847692.6A EP2097064B1 (en) | 2006-12-04 | 2007-12-03 | Anaplerotic therapy of huntington disease and other polyglutamine diseases |
| PCT/EP2007/063181 WO2008068230A1 (en) | 2006-12-04 | 2007-12-03 | Anaplerotic therapy of huntington disease and other polyglutamine diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2097064T3 true PL2097064T3 (pl) | 2016-02-29 |
Family
ID=37733780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07847692T PL2097064T3 (pl) | 2006-12-04 | 2007-12-03 | Terapia anaplerotyczna choroby Huntingtona i innych chorób poliglutaminowych |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US20100063147A1 (pl) |
| EP (3) | EP1929995A1 (pl) |
| CY (1) | CY1116938T1 (pl) |
| DK (1) | DK2097064T3 (pl) |
| ES (2) | ES2778525T3 (pl) |
| HK (1) | HK1223829A1 (pl) |
| HU (1) | HUE026217T2 (pl) |
| PL (1) | PL2097064T3 (pl) |
| PT (1) | PT2097064E (pl) |
| SI (1) | SI2097064T1 (pl) |
| WO (1) | WO2008068230A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1929995A1 (en) | 2006-12-04 | 2008-06-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Anaplerotic therapy of Huntington disease and other polyglutamine diseases |
| JP5765839B2 (ja) * | 2009-12-05 | 2015-08-19 | 国立大学法人名古屋大学 | 球脊髄性筋萎縮症治療薬 |
| WO2011082111A1 (en) * | 2009-12-30 | 2011-07-07 | Baylor Research Institute | Anaplerotic therapy for alzheimer's disease and the aging brain |
| EP2579867A4 (en) * | 2010-06-14 | 2014-03-19 | Baylor Res Inst | TRIHEPTANOIN REGIME FOR THE TREATMENT OF ADULT POLYGLUCOSAN BODY DISEASE (APBD) |
| AU2013358951C1 (en) * | 2012-12-13 | 2019-06-27 | Baylor Research Institute | Triheptanoin for the treatment of glucose transporter 1 deficiency |
| US9833430B2 (en) | 2013-11-14 | 2017-12-05 | The University Of Queensland | Neurodegenerative disorders and methods of treatment and diagnosis thereof |
| US20170161441A1 (en) * | 2014-07-02 | 2017-06-08 | Ridge Diagnostics, Inc. | Methods and materials for treating pain and depression |
| CN117298092A (zh) | 2016-06-08 | 2023-12-29 | 善睿圣医药保健股份有限公司 | 具有奇数碳的脂类化合物及其作为医药组合物或者营养补充剂的用途 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4025649A (en) | 1974-08-19 | 1977-05-24 | Labaz | Acetic acid derivatives having pharmacological activity and compositions containing the same |
| DE3032300A1 (de) | 1980-08-27 | 1982-04-01 | Alfred Ing. Wien Lohninger | Mittel zur parenteralen ernaehrung |
| GB2104079B (en) | 1981-08-14 | 1985-08-21 | London Polytech | New aminoacid isomers, their production and their medicinal use |
| US4753963A (en) | 1985-09-26 | 1988-06-28 | The Procter & Gamble Company | Nutritional fat suitable for enteral and parenteral products |
| JP3486778B2 (ja) | 1993-04-02 | 2004-01-13 | 三菱ウェルファーマ株式会社 | アルツハイマー病予防治療剤 |
| US20090253781A1 (en) | 2002-05-24 | 2009-10-08 | Btg International Limited | Therapeutic compositions |
| US6740679B1 (en) * | 1999-02-05 | 2004-05-25 | Baylor University Medical Center | Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
| NZ513329A (en) | 1999-02-05 | 2003-11-28 | Baylor University Medical Ct | Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
| US6335361B1 (en) | 1999-11-03 | 2002-01-01 | Juvenon Inc. | Method of treating benign forgetfulness |
| DE60138019D1 (de) | 2000-05-01 | 2009-04-30 | Accera Inc | Verwendung von triglyceriden mit mittellangen ketten zur behandlung und vorbeugung der alzheimerschen erkrankung |
| US6835750B1 (en) * | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| JP2006519843A (ja) * | 2003-03-06 | 2006-08-31 | アクセラ・インコーポレーテッド | 新規化学物質及び代謝異常の治療におけるそれらの使用法 |
| US8399515B2 (en) | 2003-05-20 | 2013-03-19 | Baylor Research Institute | Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements |
| US8106093B2 (en) | 2004-07-02 | 2012-01-31 | Baylor Research Institute | Glycogen or polysaccharide storage disease treatment method |
| US7884115B2 (en) | 2004-09-28 | 2011-02-08 | Allergan, Inc. | Methods and compositions for the treatment of pain and other neurological conditions |
| HUE040002T2 (hu) | 2006-04-03 | 2019-02-28 | Accera Inc | Ketogén vegyületek alkalmazása korfüggõ memóriazavar kezelésére |
| EP2083813A4 (en) | 2006-09-26 | 2011-04-27 | Baylor Res Inst | NUTRIENT SENSOR |
| EP1929995A1 (en) | 2006-12-04 | 2008-06-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Anaplerotic therapy of Huntington disease and other polyglutamine diseases |
| PT2650382E (pt) | 2007-07-31 | 2016-01-14 | Accera Inc | Utilização de testagem genómica e compostos cetogénicos para o tratamento de função cognitiva reduzida |
| WO2009124250A1 (en) | 2008-04-03 | 2009-10-08 | The Trustees Of The University Of Pennsylvania | Compositions and methods for detecting tricarboxylic acid (tca) metabolic flux |
| WO2011082111A1 (en) | 2009-12-30 | 2011-07-07 | Baylor Research Institute | Anaplerotic therapy for alzheimer's disease and the aging brain |
| US20110301238A1 (en) | 2010-06-02 | 2011-12-08 | Borges Karin | Seizure related disorders and therapeutic methods thereof |
| EP2579867A4 (en) | 2010-06-14 | 2014-03-19 | Baylor Res Inst | TRIHEPTANOIN REGIME FOR THE TREATMENT OF ADULT POLYGLUCOSAN BODY DISEASE (APBD) |
| CA2822898C (en) | 2010-12-23 | 2021-01-05 | Amazentis Sa | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders |
| AU2013358951C1 (en) | 2012-12-13 | 2019-06-27 | Baylor Research Institute | Triheptanoin for the treatment of glucose transporter 1 deficiency |
| US9833430B2 (en) | 2013-11-14 | 2017-12-05 | The University Of Queensland | Neurodegenerative disorders and methods of treatment and diagnosis thereof |
-
2006
- 2006-12-04 EP EP06291873A patent/EP1929995A1/en not_active Withdrawn
-
2007
- 2007-12-03 ES ES15175719T patent/ES2778525T3/es active Active
- 2007-12-03 WO PCT/EP2007/063181 patent/WO2008068230A1/en active Application Filing
- 2007-12-03 HU HUE07847692A patent/HUE026217T2/en unknown
- 2007-12-03 PL PL07847692T patent/PL2097064T3/pl unknown
- 2007-12-03 SI SI200731703T patent/SI2097064T1/sl unknown
- 2007-12-03 EP EP07847692.6A patent/EP2097064B1/en active Active
- 2007-12-03 PT PT78476926T patent/PT2097064E/pt unknown
- 2007-12-03 US US12/516,486 patent/US20100063147A1/en not_active Abandoned
- 2007-12-03 EP EP15175719.2A patent/EP3009135B1/en active Active
- 2007-12-03 DK DK07847692.6T patent/DK2097064T3/en active
- 2007-12-03 ES ES07847692.6T patent/ES2552843T3/es active Active
-
2011
- 2011-12-30 US US13/341,028 patent/US20120165405A1/en not_active Abandoned
-
2014
- 2014-06-19 US US14/308,966 patent/US9717705B2/en active Active
-
2015
- 2015-11-13 CY CY20151101025T patent/CY1116938T1/el unknown
-
2016
- 2016-10-20 HK HK16112074.6A patent/HK1223829A1/zh unknown
-
2017
- 2017-06-30 US US15/640,018 patent/US10220014B2/en active Active
-
2019
- 2019-02-04 US US16/267,210 patent/US20190365695A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3009135A1 (en) | 2016-04-20 |
| EP2097064A1 (en) | 2009-09-09 |
| PT2097064E (pt) | 2015-11-25 |
| CY1116938T1 (el) | 2017-04-05 |
| US20120165405A1 (en) | 2012-06-28 |
| DK2097064T3 (en) | 2015-11-23 |
| ES2552843T3 (es) | 2015-12-02 |
| HK1223829A1 (zh) | 2017-08-11 |
| HUE026217T2 (en) | 2016-05-30 |
| EP3009135B1 (en) | 2020-02-05 |
| US20180021287A1 (en) | 2018-01-25 |
| EP1929995A1 (en) | 2008-06-11 |
| US9717705B2 (en) | 2017-08-01 |
| ES2778525T3 (es) | 2020-08-10 |
| SI2097064T1 (sl) | 2016-01-29 |
| US20100063147A1 (en) | 2010-03-11 |
| US10220014B2 (en) | 2019-03-05 |
| WO2008068230A1 (en) | 2008-06-12 |
| EP2097064B1 (en) | 2015-08-19 |
| US20140364498A1 (en) | 2014-12-11 |
| US20190365695A1 (en) | 2019-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2182983A4 (en) | TREATMENT OF AMYLOIDOGENIC DISEASES | |
| SI2097064T1 (sl) | Anaplerotična terapija huntingtonove bolezni in drugih poliglutaminskih bolezni | |
| EP1968607A4 (en) | TREATMENT OF CANCER AND OTHER DISEASES | |
| PL2056863T3 (pl) | Leczenie chorób oczu | |
| BRPI0720046A2 (pt) | Composição de suplemento nutricional para tratamento de doenças oculares | |
| EP2118300A4 (en) | PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGEN DISEASES | |
| SI2056807T1 (sl) | Zdravljenje vnetnih bolezni | |
| HK1201046A1 (en) | Methods of treating ophthalmic diseases | |
| SI2056842T1 (sl) | Modificiran galaktosil-ceramid za zdravljenje kancerogenih obolenj | |
| EP1962839A4 (en) | ADMINISTRATION OF A MNTOR INHIBITOR FOR THE TREATMENT OF PATIENTS WITH CANCER | |
| EP2004204A4 (en) | TREATMENT OF NEURODEGENERATIVE DISEASES | |
| EP2160100B8 (en) | Treatment of graft-versus-host disease | |
| HK1148684A1 (en) | Treatment of prion protein related diseases | |
| ZA200806808B (en) | Treatment of stressed patients | |
| EP1962869A4 (en) | TREATMENT OF RESPIRATORY DISEASES | |
| EP2026822A4 (en) | TOPICAL TREATMENT FOR EYE SURGERY DISEASES | |
| GB0610183D0 (en) | Treatment of neurodegenerative diseases | |
| EP2001488A4 (en) | PREVENTION AND TREATMENT OF CANCER AND OTHER DISEASES | |
| EP2056858A4 (en) | TREATMENT OF PULMONARY DISEASE CONDITIONS | |
| GB0914423D0 (en) | Treatment of protein aggregation diseases | |
| BRPI0821539A2 (pt) | composição para a prevenção e o tratamento de doenças metabólicas compreendendo o extrato de lysimachiae foenum-graeci herma | |
| EP2025342A4 (en) | THERAPEUTIC AGENT OR DEVELOPMENT INHIBITOR OF POLYGLUTAMINE DISEASE | |
| EP2059238A4 (en) | THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS | |
| GB0623740D0 (en) | Treatment of disease | |
| GB0622136D0 (en) | Treatment of gastrointestinal diseases |